Visitors Now:
Total Visits:
Total Stories:
Profile image
Story Views

Now:
Last Hour:
Last 24 Hours:
Total:

Global Reliance Life Sciences Pvt. Ltd. Market 2016 Share, Trend, Segmentation and Forecast to 2022

Monday, October 10, 2016 4:34
% of readers think this story is Fact. Add your two cents.

(Before It's News)

Summary

Global Markets Direct’s, ‘Reliance Life Sciences Pvt. Ltd. – Product Pipeline Review – 2016’, provides an overview of the Reliance Life Sciences Pvt. Ltd.’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Reliance Life Sciences Pvt. Ltd., complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Complete report details @ https://www.wiseguyreports.com/reports/649768-reliance-life-sciences-pvt-ltd-product-pipeline-review-2016

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

- The report provides a snapshot of the pipeline therapeutic landscape of Reliance Life Sciences Pvt. Ltd. 
- The report provides overview of Reliance Life Sciences Pvt. Ltd. including its business description, key facts, and locations and subsidiaries 
- The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities 
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages 
- The report assesses Reliance Life Sciences Pvt. Ltd.’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type 
- The report features Reliance Life Sciences Pvt. Ltd.’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Request a sample report @ https://www.wiseguyreports.com/sample-request/649768-reliance-life-sciences-pvt-ltd-product-pipeline-review-2016

Reasons to buy

- Evaluate Reliance Life Sciences Pvt. Ltd.’s strategic position with total access to detailed information on its product pipeline 
- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies 
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage 
- Identify and understand important and diverse types of therapeutics under development for Reliance Life Sciences Pvt. Ltd. 
- Identify potential new clients or partners in the target demographic 
- Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics 
- Devise corrective measures for pipeline projects by understanding Reliance Life Sciences Pvt. Ltd.’s pipeline depth and focus of pipeline therapeutics 
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Make an enquiry before buying this Report @ https://www.wiseguyreports.com/enquiry/649768-reliance-life-sciences-pvt-ltd-product-pipeline-review-2016

Key points in table of content

Table of Contents 
Table of Contents 2 
List of Tables 4 
List of Figures 4 
Reliance Life Sciences Pvt. Ltd. Snapshot 5 
Reliance Life Sciences Pvt. Ltd. Overview 5 
Key Information 5 
Key Facts 5 
Reliance Life Sciences Pvt. Ltd. – Research and Development Overview 6 
Key Therapeutic Areas 6 
Reliance Life Sciences Pvt. Ltd. – Pipeline Review 8 
Pipeline Products by Stage of Development 8 
Pipeline Products – Monotherapy 9 
Pipeline Products – Out-Licensed Products 10 
Out-Licensed Products/Combination Treatment Modalities 11 
Reliance Life Sciences Pvt. Ltd. – Pipeline Products Glance 12 
Reliance Life Sciences Pvt. Ltd. – Late Stage Pipeline Products 12 
Phase III Products/Combination Treatment Modalities 12 
Reliance Life Sciences Pvt. Ltd. – Clinical Stage Pipeline Products 13 
Phase II Products/Combination Treatment Modalities 13 
Reliance Life Sciences Pvt. Ltd. – Early Stage Pipeline Products 14 
Preclinical Products/Combination Treatment Modalities 14 
Discovery Products/Combination Treatment Modalities 15 
Reliance Life Sciences Pvt. Ltd. – Unknown Stage Pipeline Products 16 
Unknown Products/Combination Treatment Modalities 16 
Reliance Life Sciences Pvt. Ltd. – Drug Profiles 17 
cetuximab biosimilar 17 
Product Description 17 
Mechanism of Action 17 
R&D Progress 17 
darbepoetin alfa 18 
Product Description 18 
Mechanism of Action 18 
R&D Progress 18 
pegfilgrastim 19 
Product Description 19 
Mechanism of Action 19 
R&D Progress 19 
etanercept biosimilar 20 
Product Description 20 
Mechanism of Action 20 
R&D Progress 20 
Antisense RNAi Oligonucleotides for Undisclosed Indications 21 
Product Description 21 
Mechanism of Action 21 
R&D Progress 21 
RSCL-0520 22 
Product Description 22 
Mechanism of Action 22 
R&D Progress 22 
somatropin biosimilar 23 
Product Description 23 
Mechanism of Action 23 
R&D Progress 23 
Monoclonal Antibodies for Oncology and Inflammation 24 
Product Description 24 
Mechanism of Action 24 
R&D Progress 24 
RSCL-0521 25 
Product Description 25 
Mechanism of Action 25 
R&D Progress 25 
NeuroRel 26 
Product Description 26 
Mechanism of Action 26 
R&D Progress 26 
Reliance Life Sciences Pvt. Ltd. – Pipeline Analysis 27 
Reliance Life Sciences Pvt. Ltd. – Pipeline Products by Target 27 
Reliance Life Sciences Pvt. Ltd. – Pipeline Products by Route of Administration 28 
Reliance Life Sciences Pvt. Ltd. – Pipeline Products by Molecule Type 29 
Reliance Life Sciences Pvt. Ltd. – Pipeline Products by Mechanism of Action 30 
Reliance Life Sciences Pvt. Ltd. – Dormant Projects 31 
Reliance Life Sciences Pvt. Ltd. – Locations And Subsidiaries 32 
Head Office 32 
Other Locations & Subsidiaries 32 
Appendix 34 
Methodology 34 
Coverage 34 
Secondary Research 34 
Primary Research 34 
Expert Panel Validation 34 
Contact Us 34 
Disclaimer 35

List of Tables 
Reliance Life Sciences Pvt. Ltd., Key Information 5 
Reliance Life Sciences Pvt. Ltd., Key Facts 5 
Reliance Life Sciences Pvt. Ltd. – Pipeline by Indication, 2016 7 
Reliance Life Sciences Pvt. Ltd. – Pipeline by Stage of Development, 2016 8 
Reliance Life Sciences Pvt. Ltd. – Monotherapy Products in Pipeline, 2016 9 
Reliance Life Sciences Pvt. Ltd. – Out-Licensed Products in Pipeline, 2016 10 
Reliance Life Sciences Pvt. Ltd. – Out-Licensed Products/ Combination Treatment Modalities, 2016 11 
Reliance Life Sciences Pvt. Ltd. – Phase III, 2016 12 
Reliance Life Sciences Pvt. Ltd. – Phase II, 2016 13 
Reliance Life Sciences Pvt. Ltd. – Preclinical, 2016 14 
Reliance Life Sciences Pvt. Ltd. – Discovery, 2016 15 
Reliance Life Sciences Pvt. Ltd. – Unknown, 2016 16 
Reliance Life Sciences Pvt. Ltd. – Pipeline by Target, 2016 27 
Reliance Life Sciences Pvt. Ltd. – Pipeline by Route of Administration, 2016 28 
Reliance Life Sciences Pvt. Ltd. – Pipeline by Molecule Type, 2016 29 
Reliance Life Sciences Pvt. Ltd. – Pipeline Products by Mechanism of Action, 2016 30 
Reliance Life Sciences Pvt. Ltd. – Dormant Developmental Projects,2016 31 
Reliance Life Sciences Pvt. Ltd., Other Locations 32 
Reliance Life Sciences Pvt. Ltd., Subsidiaries 33

Get this report @ https://www.wiseguyreports.com/checkout?currency=one_user-USD&report_id=649768

Contact US:

NORAH TRENT

Partner Relations & Marketing Manager

sales@wiseguyreports.com

Ph: +1-646-845-9349 (US)

Ph: +44 208 133 9349 (UK)

Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

Top Stories
Recent Stories

Register

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.